William Tanner

Stock Analyst at Cantor Fitzgerald

(0.97)
# 3,442
Out of 4,805 analysts
5
Total ratings
20%
Success rate
-2.35%
Average return

Stocks Rated by William Tanner

Prothena Corporation
Mar 4, 2019
Assumes: Overweight
Price Target: n/a
Current: $9.69
Upside: -
TherapeuticsMD
Aug 14, 2018
Maintains: Overweight
Price Target: $1,300$1,350
Current: $0.88
Upside: +154,009.59%
Xencor
Nov 29, 2017
Initiates: Overweight
Price Target: $33
Current: $7.92
Upside: +316.67%